Scheduling of a Primary Cell from a Secondary Cell
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 62/954,642, filed Dec 29, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,064,513 | Scheduling of a Primary Cell from a Secondary Cell In force · High confidence | Panpsy Technologies, LLC | In force | High confidence | ||
| US 11,252,750 | Scheduling of a Primary Cell from a Secondary Cell In force · High confidence | Panpsy Technologies, LLC | In force | High confidence | ||
| US 11,405,946 | Scheduling of a Primary Cell from a Secondary Cell In force · Low confidence | Panpsy Technologies, LLC | In force | Low confidence | ||
| US 11,737,098 | Scheduling of a Primary Cell from a Secondary Cell In force · Low confidence | Panpsy Technologies, LLC | In force | Low confidence | ||
| US 12,127,200 | Scheduling of a Primary Cell from a Secondary Cell In force · Medium confidence | Panpsy Technologies, LLC | In force | Medium confidence | ||
| Application 18/892,346 | Scheduling of a Primary Cell from a Secondary Cell Pending Not granted | Panpsy Technologies, LLC | Pending | Not granted | not computed |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Panpsy Technologies, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.